Cannabidiol prescription in clinical practice: an audit on the first 400 patients in New Zealand.
Graham GulbransenWilliam XuBruce ArrollPublished in: BJGP open (2020)
There may be analgesic and anxiolytic benefits of CBD in patients with non-cancer chronic pain and mental health conditions such as anxiety. CBD is well tolerated, making it safe to trial for non-cancer chronic pain, mental health, neurological, and cancer symptoms.
Keyphrases
- chronic pain
- mental health
- papillary thyroid
- squamous cell
- end stage renal disease
- clinical trial
- ejection fraction
- pain management
- newly diagnosed
- chronic kidney disease
- randomized controlled trial
- study protocol
- sleep quality
- peritoneal dialysis
- prognostic factors
- spinal cord
- blood brain barrier
- neuropathic pain
- subarachnoid hemorrhage
- open label